Schoenherr advises Roche on acquisition of mySugr
Schoenherr has advised the Roche Group on the acquisition of all shares of mySugr. With more than one million users globally, mySugr is one of the leading mobile diabetes platforms, which will become an integral part of Roche’s new patient-centred digital health services platform in diabetes care. The Schoenherr team advising Roche as lead counsel […]